Impact News +++ Glencore startet Aktienrückkaufprogramm von bis zu 1 Milliarde US-Dollar (Cash) +++ GLENCORE Aktie -3,74%

NYXOAH Aktie

>NYXOAH Performance

1 Woche: 0%

1 Monat: +9,1%

3 Monate: +8,7%

6 Monate: -13,2%

1 Jahr: +8,0%

laufendes Jahr: -9,4%

>NYXOAH Aktie

Name:

NYXOAH S.A.

Land:

Belgien

Sektor:

Gesundheit

ISIN/ Wkn:

BE0974358906 / A2QCWK

Symbol/ Ticker:

5YI (Frankfurt)

Kürzel:

FRA:5YI, ETR:5YI, 5YI:GR

Index:

Webseite:

https://www.nyxoah.com/

Marktkapitalisierung:

252.65 Mio. EUR

Umsatz:

4.36 Mio. EUR

EBITDA:

-66.41 Mio. EUR

Gewinn je Aktie:

-1.99 EUR

Schulden:

22.09 Mio. EUR

Liquide Mittel:

63.05 Mio. EUR

Umsatz-/ Gewinnwachstum:

-12.9% / -

KGV/ KGV lG:

- / -

KUV/ KBV/ PEG:

52.91 / 2.66 / -

Gewinnm./ Eigenkapitalr.:

- / -77.44%

Dividende je Aktie:

Dividendenrendite/ -schätzung:

- / -

Insiderhandel:

Suchwörter:

NYXOAH

Letzte Datenerhebung:

07.07.25

>NYXOAH Eigentümer

Aktien: 37.43 Mio. St.

f.h. Aktien: 12.79 Mio. St.

Insider Eigner: 41.73%

Instit. Eigner: 25.57%

Leerverk. Aktien: -

>NYXOAH Peer Group

BIOCARTIS

BIOSENIC

CELYAD

FAGRON

GALAPAGOS

HYLORIS

ION BEAM

OXURION

SEQUANA

UCB

>NYXOAH Chart & Kurs - Stuttgart

>NYXOAH News

28.05.25 - 22:33	Nyxoah to Present at the Jefferies Global Healthcare Conference (GlobeNewswire EN)
	Nyxoah to Present at the Jefferies Global Healthcare Conference...

14.05.25 - 20:42	Nyxoah outlines U.S. Genio launch plan with 50-member team as FDA approval expected Q2 2025 (SeekingAlpha)
	Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...

14.05.25 - 15:00	Nyxoah SA (NYXH) Reports Q1 Loss, Lags Revenue Estimates (Zacks)
	Nyxoah (NYXH) delivered earnings and revenue surprises of -28.57% and 29.71%, respectively, for the quarter ended March 2025. Do the numbers hold clues to what lies ahead for the stock?...

14.05.25 - 14:33	Nyxoah GAAP EPS of €0.60, revenue of €1.06M (SeekingAlpha)
	Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...

14.05.25 - 07:03	Nyxoah Reports First Quarter Financial and Operating Results (GlobeNewswire EN)
	REGULATED INFORMATION...

14.05.25 - 07:03	Corporate News: Nyxoah SA. (EQS)
	Nyxoah gibt Finanzergebnisse und operatives Update für das erste Quartal bekannt...

12.05.25 - 23:48	INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Nyxoah S.A. - NYXH (PR Newswire)
	NEW YORK, May 12, 2025 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Nyxoah S.A. ("Nyxoah" or the "Company") (NASDAQ: NYXH). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The investigation......

07.05.25 - 22:33	Nyxoah to Release First Quarter 2025 Financial Results on May 14, 2025 (GlobeNewswire EN)
	Nyxoah to Release First Quarter 2025 Financial Results on May 14, 2025...

06.05.25 - 22:15	INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Nyxoah S.A. - NYXH (PR Newswire)
	NEW YORK, May 6, 2025 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Nyxoah S.A. ("Nyxoah" or the "Company") (NASDAQ: NYXH). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The investigation......

29.04.25 - 00:12	INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Nyxoah S.A. - NYXH (PR Newswire)
	NEW YORK, April 28, 2025 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Nyxoah S.A. ("Nyxoah" or the "Company") (NASDAQ: NYXH). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The investigation......

22.04.25 - 22:01	INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Nyxoah S.A. - NYXH (PR Newswire)
	NEW YORK, April 22, 2025 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Nyxoah S.A. ("Nyxoah" or the "Company") (NASDAQ: NYXH). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The investigation......

15.04.25 - 00:21	INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Nyxoah S.A. - NYXH (PR Newswire)
	NEW YORK, April 14, 2025 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Nyxoah S.A. ("Nyxoah" or the "Company") (NASDAQ: NYXH). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The investigation......

08.04.25 - 16:09	INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Nyxoah S.A. - NYXH (PR Newswire)
	NEW YORK, April 8, 2025 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Nyxoah S.A. ("Nyxoah" or the "Company") (NASDAQ: NYXH). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The investigation......

08.04.25 - 11:48	Nyxoah erwartet FDA-Freigabe für Genio noch im Frühjahr (4investors)
	Um den gesamten Artikel unter 4investors.de zu lesen, klicken Sie bitte auf die Überschrift...

08.04.25 - 07:03	Nyxoah Provides Update on FDA Approvable Letter for Genio System (GlobeNewswire EN)
	Nyxoah Provides Update on FDA Approvable Letter for Genio System Expects to meet final FDA requirements for full PMA approval in the second quarter...

08.04.25 - 07:03	Corporate News: Nyxoah SA. (EQS)
	Nyxoah Provides Update on FDA Approvable Letter for Genio System...

07.04.25 - 15:36	NYXH Investors Have Opportunity to Join Nyxoah S.A. Fraud Investigation with the Schall Law Firm (PR Newswire)
	LOS ANGELES, April 7, 2025 /PRNewswire/ -- The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Nyxoah S.A. ("Nyxoah" or "the Company") (NASDAQ: NYXH) for violations of the securities laws. The......

31.03.25 - 20:12	INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Nyxoah S.A. - NYXH (PR Newswire)
	NEW YORK, March 31, 2025 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Nyxoah S.A. ("Nyxoah" or the "Company") (NASDAQ: NYXH). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The investigation......

26.03.25 - 15:45	Nyxoah: FDA signalisiert mögliche Zulassung für Genio-System (4investors)
	Um den gesamten Artikel unter 4investors.de zu lesen, klicken Sie bitte auf die Überschrift...

26.03.25 - 09:48	Corporate News: Nyxoah SA. (EQS)
	Nyxoah erhält Approvable Letter für sein Genio®-System von der FDA...

>weitere News anzeigen...

>Impressum >Über uns >Datenschutz >Financial Data & Solutions

>Behalte deine Investments mit realtime Kursen & News im Blick. Finde neue spannende Aktien! Registriere Dich und werde Mitglied!

Zitat des Tages: Es geht nichts über ein ruhiges Leben, wie der Mann sagte, als er die Stelle eines Leuchtturmwärters annahm. - Charles Dickens

Partner: >Tradegate Börse | >Dukascopy | >Boersentreff- Partner

Börsentreff auf Facebook |

Börsentreff auf X |

Börsentreff auf Instagram